Biotech companies this week spent on experimental therapies, including autoimmune drugs, next-generation obesity pills and cancer combinations. Novartis…
Novartis NVS announced that the late-stage study on investigational candidate, pelacarsen, failed. Pelacarsen is an investigational antisense oligonucleotide…
Novartis NVS announced that the late-stage study on investigational candidate, pelacarsen, failed. Pelacarsen is an investigational antisense oligonucleotide…